Study of TST005 in Patients With Locally Advanced or Metastatic Solid Tumors

NCT04958434 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

19

Enrollment

INDUSTRY

Sponsor class

Stopped Corporate Decision

Conditions

Locally Advanced or Metastatic Cancers
Metastatic Human Papillomavirus-Related Malignant Neoplasm

Interventions

DRUG: TST005

Sponsor

Suzhou Transcenta Therapeutics Co., Ltd.